Welcome to our dedicated page for Medirom Healthcare Technologies SEC filings (Ticker: MRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MEDIROM Healthcare Technologies Inc. filings document a foreign private issuer that reports to the SEC on Form 6-K and annual reports under Form 20-F. The company’s disclosures cover its Japan-based wellness salon operations, digital preventive healthcare products, ADR/ADS voting materials, and current reports furnished for press releases and material corporate events.
MRM filings include ordinary general meeting notices and proxy cards for common share and American Depositary Share holders, convertible-type corporate bond issuances under Japanese law, loan and maturity-extension agreements, registration statement incorporation references, KPI reporting changes, and partnership updates for World ID, Orb authentication, MOTHER Bracelet and REMONY. These records also describe capital structure, governance procedures, financing terms, risk language and foreign-issuer reporting mechanics.
Medirom Healthcare Technologies Inc. (MRM) has an updated ownership report from major shareholder Kouji Eguchi and affiliated entity COZY LLC. Eguchi now beneficially owns 2,031,558 common shares, including options exercisable within 60 days and shares held through COZY, representing 25.11% of the assumed outstanding common shares.
This amendment reflects two key changes: Eguchi received a grant of 36,500 stock options on July 18, 2025 at an exercise price of $1.74, exercisable from July 18, 2026 to July 17, 2030 subject to revenue targets; and on August 27, 2026 he transferred 79,945 common shares to an unrelated third party for no consideration. COZY LLC alone beneficially owns 47,543 common shares, or 0.60% of the 7,901,950 common shares outstanding as of June 30, 2025. Eguchi also holds 150,000 stock options with a JPY 2,000 exercise price and one Class A share, the only Class A share outstanding.
Medirom Healthcare Technologies Inc. (MRM) reported that Chief Executive Officer and director Eguchi Kouji disposed of 79,945 Common Shares on 2026-08-27 in a transaction coded "J". According to a footnote, these shares were transferred to an unrelated third party for no consideration. After this disposition, Eguchi directly held 1,797,515 Common Shares. Additional indirect holdings are reported through American Depositary Shares and COZY LLC, a Japanese limited liability company wholly owned and controlled by Eguchi.
Medirom Healthcare Technologies Inc. (MRM) reported key operating metrics for 2026Q2, highlighting mixed trends in its core salon business and growing traction in digital health. The salon segment generated an average Revenue Per Customer of 7,597 JPY, up 5.7% year-on-year and well above Japanese industry averages for both female and male customers.
The number of salons declined to 282 and total quarterly customers were 192k, down 17.7% year-on-year as staff were partially reallocated to promote “World ID,” which management states still maintained overall economic rationality by adding contract revenue. Key salon KPIs included a 77.2% repeat ratio and 44.2% operating ratio.
In the HealthTech business “Lav®,” the number of cooperating insurers reached 109 and cumulative users of Specified Health Guidance rose to 13,921, an increase of 3,270 from 2025Q2. The REMONY® remote health management system tripled its deployment scale within the Japan Ground Self-Defense Force 8th Division, and an expanded partnership with TD SYNNEX targets enterprise heatstroke-prevention use cases. Re.Ra.Ku® “eGift” ticket sales for Father’s Day surged about 1,500% year-on-year following a 30% discount campaign.
Medirom Healthcare Technologies Inc. (MRM) reports operational progress with its partnership with World on the World ID “Proof of Human” infrastructure in Japan. The company states that cumulative human verifications through World ID’s Orb devices at its stores surpassed 50,000 as of July 14, 2026, including at Re.Ra.Ku wellness studios operated by subsidiary Wellness Co.
After this initial outreach phase, the company plans to shift from event-based pop-up verification booths to more permanent Orb installations at approximately 300 stores, aiming to provide stable and dependable access to World ID verification. Medirom also indicates continued participation in the World project and an intention to explore additional applications of health-related data at the intersection of healthcare and technology.
Healthcare Technologies Inc. previously issued Fourth Unsecured Convertible-Type Corporate Bonds with Share Options to Kufu Company Holdings Inc. with an aggregate principal of JPY 275,000,000, bearing interest at 5.0% per annum and scheduled to mature on June 30, 2026. Separately, it entered into a Deemed Loan Agreement for JPY 200,000,000 at 10.0% per annum, repayable on December 31, 2026, secured by a first-priority pledge over all shares of subsidiary MOTHER Labs Inc.
Effective on the bond maturity date, the parties executed an Amendment dated July 14, 2026 under which, in lieu of cash repayment, the bond holder refinanced the entire JPY 275,000,000 bond principal into an additional loan. As a result, total principal under the Loan Agreement increased to JPY 475,000,000, and the Share Pledge Agreement was amended to secure this larger amount, while other loan and pledge terms remained unchanged.
Healthcare Technologies Inc. reports that Nasdaq has granted additional time to cure a filing deficiency. The company had been found non-compliant with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Form 20-F for the fiscal year ended December 31, 2025. After Healthcare Technologies submitted a compliance plan by July 27, 2026, Nasdaq extended the deadline to regain compliance to November 11, 2026.
The company states it is working diligently to complete and file the delayed Form 20-F as promptly as practicable. If it does not regain compliance by November 11, 2026, Nasdaq will move to delist its American Depositary Shares, a determination the company would be able to appeal to a Nasdaq Hearings Panel.
Kufu Company Holdings, Inc. filed Amendment No. 3 to its Schedule 13D concerning Medirom Healthcare Technologies Inc. American depositary shares. The amendment reports that Kufu now beneficially owns 0 common shares and 0% of the class.
On July 14, 2026, bonds previously held by Kufu were redeemed in full. As a result, the reporting person has no voting or dispositive power over Medirom shares. This amendment is described as the final amendment and constitutes an exit filing for the reporting person.
Healthcare Technologies Inc., through its subsidiary MOTHER Labs, reports that the Japan Ground Self-Defense Force 8th Division has placed an additional order for its REMONY® remote health monitoring system. The new order expands deployment to approximately three times the initial implementation scale.
REMONY® combines the recharge-free MOTHER Bracelet® smart tracker with a dedicated gateway, enabling 24/7 vital-sign monitoring without charging interruptions. JGSDF highlighted the system’s usefulness for heatstroke prevention and continuous health tracking during prolonged, harsh training environments, supporting real-time alerts for issues such as abnormal heart rate, falls, and heat-related risk.
Medirom Healthcare Technologies Inc. director Uekusa Yoshio filed an initial ownership report showing a direct holding of common shares. The filing states this position is represented by 28,837 American Depositary Shares. This Form 3 does not report any new purchase or sale, only existing ownership.
Healthcare Technologies Inc. has received a Nasdaq notice stating it is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it failed to timely file its Form 20-F for the year ended December 31, 2025. The notice does not immediately affect trading of its American Depositary Shares on the Nasdaq Capital Market.
The company has 60 days from the May 26, 2026 notice, until July 27, 2026, to submit a plan to regain compliance, and Nasdaq may grant up to 180 days, until November 11, 2026, to cure the deficiency if the plan is accepted. Healthcare Technologies plans to file its Form 20-F or provide a compliance plan by July 27, 2026, but there is no assurance Nasdaq will accept the plan or extend the deadline.